Investment Philosophy
Capital should notstay where itwas earned.
IGUAKO does not define itself by a single industry. The philosophy is capital mobility: the right to move resources toward whichever opportunity is genuinely the strongest.
The Premise
An advantage discovered in pharmaceuticals does not require capital to remain in pharmaceuticals.
Most firms are organised around the market they know. That organisation is comfortable and it quietly caps returns, because the obligation to deploy inside a category outlives the conditions that made the category attractive.
IGUAKO is organised around the opposite premise. The sourcing engine sits in specialised markets: pharmaceuticals, biological and animal-derived industries, and other complex asset classes where regulatory, operational and informational barriers keep competition thin. The deployment engine sits wherever the arithmetic is best, which is frequently somewhere else entirely: information infrastructure, data analytics, technology, financial systems, quantitative strategies and private enterprise.
The discipline this demands is unsentimentality about origin. A business that produced an excellent return is not thereby entitled to the next allocation.
The Cycle
Advantage becomesequity, equity becomescapital, capitalbecomes leverage.
Value generated from a specialised biological market can finance a data company. Returns from private equity can support quantitative strategies. Information generated across all of it improves capital allocation elsewhere in the institution.
The objective is to keep moving resources toward whichever combination of information advantage, asymmetry, control and return potential is strongest at that moment.
Underwriting
Four tests before capital moves.
Is the advantage structural or temporary?
A pricing gap that closes when one more participant notices it is not an advantage. We underwrite for barriers that persist: licensing, physical infrastructure, contractual position, accumulated data, or genuine operating difficulty.
Can it be converted, and on what timetable?
An advantage that cannot become equity, liquidity or information within a defined period is an observation rather than an investment. Conversion path and timetable are written down before committing.
Is this the best available use of the proceeds?
Every realisation is tested against the whole opportunity set, not against the division that produced it. This is the step most institutions skip, and it is where mobility actually earns its return.
What is the loss we are prepared to accept?
Position sizing follows the downside case rather than the thesis. Illiquid and levered exposures carry an explicit maximum loss agreed before entry, not reconstructed afterwards.
The Mark
Adaptability,patience,position.
The iguana inside the monogram is not decoration. It stands for the behaviour the firm expects of itself: adaptability to the environment it finds, patience while conditions are wrong, close observation, and a willingness to hold position until the moment is actually favourable.
The three bars of the mark record the sequence that follows: capture, conversion, compounding.
Find the advantage. Capture the value.
Reallocate the capital. Compound it.